Don't throw out the baby with the bathwater!

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 2, 2005, Pages 59-60

  Kamen, Barton ^a   Kieran, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

AVASCULAR NECROSIS; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; COLORECTAL TUMOR; DEATH; DRUG SAFETY; EDITORIAL; GENITAL SYSTEM DISEASE; HEARING DISORDER; HEART FAILURE; HUMAN; INFLAMMATION; KIDNEY FAILURE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ADVERTISING; CARDIOVASCULAR DISEASES; CHILD; CHILD WELFARE; CLINICAL TRIALS; CYCLOOXYGENASE INHIBITORS; DECISION MAKING; DRUG APPROVAL; DRUG INDUSTRY; HUMANS; LACTONES; NEOPLASMS; RISK FACTORS; SULFONES;

EID: 13944264243     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000155872.67424.2e     Document Type: Editorial

References (10)

1. Angell M. The Truth About Drug Companies: How They Deceive Us and What To Do About It. Random House, 2004.
2. Snyderman R. Taking aim at pharma. Nature Med. 2004;10:1292-1293.
3. Black J. Learning by doing. Mol Interv. 2004;4:139-142.
4. Fugh-Berman A. Just say "no" to new drugs. Sun-Sentinel News, Dec. 27, 2004:23A.
5. Lenzer J. FDA to review "missing" drug company documents. Br Med J. 2005;330:7.
6. Sengupta S, Sellers LA, Cindrova T, et al. Cyclooxygenase-2-selective non-steroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis. Cancer Res. 2003;63:8351-8359.
7. Leahy KM, Ornberg RL, Wang Y, et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 2002;62:625-631.
8. Gately S, Kerbel R. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. Prog Exp Tumor Res. 2003;37:179-192.
9. Dickens DS, Kozielski R, Khan J, et al. Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol. 2002;5:356-364.
10. Dickens DS, Cripe TP. Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts. J Pediatr Hematol Oncol. 2003;25:709-714.